Cyclopharm News

Cyclopharm (ASX:CYC) | Bell Potter Healthcare Conference 2022 Presentation

28th Nov 2022

Continue Reading

We are excited to announce our partnership with Jubilant Radiopharma for the distribution of RUBY-FILL® throughout Europe

6th May 2021

Continue Reading

Cyclopharm partners with McMaster University to Evaluate Technegas® use and risks of COVID-19

4th Mar 2021

Continue Reading

USFDA Approval to File Received for Technegas™

27th May 2020

Continue Reading

Cyclopharm submits FDA approval for Technegas™

7th Apr 2020

Continue Reading

Cyclopharm Lodges NDA for Technegas® with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

23rd Mar 2020

Continue Reading

Cyclomedica will exhibit at the ANZSNM 2019 Annual Scientific Meeting

15th Apr 2019

Continue Reading

Cyclomedica will exhibit at the German Annual Meeting of Nuclear Medicine

1st Mar 2019

Continue Reading